.png?width=256&height=256&name=customer-service(1).png)
.png?width=64&height=64&name=calendrier(1).png)
.png?width=64&height=64&name=communique-de-presse(1).png)
.png?width=64&height=64&name=livre(1).png)
.png?width=64&height=64&name=blog(2).png)
In medicine, as in leadership, clarity, efficiency, and decisiveness are paramount. Oncology is no exception. Yet, too often, vital clinical data is fragmented—genomics in one system, pathology in another, radiology in yet another. This disjointed approach serves no one, least of all the patient.
A recent feature in SIH Solutions highlights an important step forward: GE Healthcare and Tribun Health have joined forces to ensure that clinicians have the full picture, without delay or uncertainty.
A System That Works for Clinicians
Strong institutions rely on strong foundations, and in healthcare, that foundation is accurate, accessible data. GE Healthcare’s VNA (Vendor Neutral Archive) and Tribun Health’s CaloPix® platform bring together multiple imaging disciplines into one integrated system. This allows clinicians to work efficiently, detect discrepancies early, and act with confidence.
Precision, Not Speculation
Decisions in oncology must be based on evidence, not assumptions. Tribun Health’s CaloPix® platform, named Best in KLAS for three years running, supports pathologists and oncologists in making precise, informed diagnoses. AI is not a substitute for expertise, but a tool to enhance it—eliminating unnecessary delays and enabling faster, more reliable treatment planning.
A Step Forward for Oncology
Progress does not come from hesitation, but from action. This partnership between GE Healthcare and Tribun Health is a decisive step towards a more efficient, intelligent approach to oncology care—one that ensures clinicians can focus on their patients, not on piecing together fragmented data.
To understand the full impact of this collaboration, 👉 read the feature in SIH Solutions. The future of oncology depends not just on innovation, but on the will to implement it.
